{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:15:53Z","timestamp":1788318953561,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014355","name":"Nirma University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004415","name":"North Atlantic Treaty Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004415","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bioorg.2024.107249","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T17:55:38Z","timestamp":1709488538000},"page":"107249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 1: triazolopyrimidine, isoxazolopyrimidine and pyrrole-based (DSM) compounds"],"prefix":"10.1016","volume":"146","author":[{"given":"Manmohan","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Tuccinardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco L.","family":"Lolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek K.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2024.107249_b0005","doi-asserted-by":"crossref","first-page":"12216","DOI":"10.3390\/ijerph191912216","article-title":"Global cross-border malaria control collaborative initiatives: a scoping review","volume":"19","author":"Fambirai","year":"2022","journal-title":"Int. J. Environ. Res. Public. Health"},{"key":"10.1016\/j.bioorg.2024.107249_b0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/13543776.2022.2049239","article-title":"Malaria transmission blocking compounds: a patent review","volume":"32","author":"Consalvi","year":"2022","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107249_b0015","article-title":"Identification of novel plasmodium falciparum dihydroorotate dehydrogenase inhibitors for malaria using in silico studies","volume":"16","author":"Alzain","year":"2022","journal-title":"Sci. Afr."},{"key":"10.1016\/j.bioorg.2024.107249_b0020","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1038\/s41467-022-30133-w","article-title":"Malaria in 2022: increasing challenges, cautious optimism","volume":"13","author":"Jagannathan","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2024.107249_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957913","article-title":"The striking mimics between COVID-19 and malaria: a review","volume":"13","author":"Konozy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2024.107249_b0030","unstructured":"World Health Organization 2022, n.d. https:\/\/cdn.who.int\/media\/docs\/default-source\/malaria\/world-malaria-reports\/world-malaria-report-2022.pdf?sfvrsn=40bfc53a_4 (accessed January 23, 2024)."},{"key":"10.1016\/j.bioorg.2024.107249_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn3256","article-title":"The fight against malaria: diminishing gains and growing challenges","volume":"14","author":"Cohen","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2024.107249_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-018-6127-9","article-title":"Plasmodium genomics: an approach for learning about and ending human malaria","volume":"118","author":"Garrido-Cardenas","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bioorg.2024.107249_b0045","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s00044-012-0216-6","article-title":"3D QSAR studies on 5-(2-methylbenzimidazol-1-yl)-N-alkylthiophene-2-carboxamide derivatives as P. falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors","volume":"22","author":"Vyas","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"2022","key":"10.1016\/j.bioorg.2024.107249_b0050","first-page":"10481","article-title":"Structure- and ligand-based drug design methods for the modeling of antimalarial agents: a review of updates from 2012 onwards","volume":"40","author":"Vyas","year":"2012","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2024.107249_b0055","unstructured":"World malaria report 2021, (n.d.). https:\/\/www.scribd.com\/document\/571513206\/9789240040496-eng# (accessed March 27, 2023)."},{"key":"10.1016\/j.bioorg.2024.107249_b0060","unstructured":"World Health Organization 2023, n.d. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023 (accessed January 23, 2024)."},{"key":"10.1016\/j.bioorg.2024.107249_b0065","article-title":"Indoor residual spraying for preventing malaria in communities using insecticide-treated nets","volume":"2022","author":"Pryce","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioorg.2024.107249_b0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s12936-021-03833-9","article-title":"Effectiveness of long-lasting insecticidal nets in prevention of malaria among individuals visiting health centres in Ziway-Dugda District, Ethiopia: matched case\u2013control study","volume":"20","author":"Wubishet","year":"2021","journal-title":"Malar. J."},{"key":"10.1016\/j.bioorg.2024.107249_b0075","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/s41598-021-81343-z","article-title":"The antimalarial efficacy and mechanism of resistance of the novel chemotype DDD01034957","volume":"11","author":"Miguel-Blanco","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2024.107249_b0080","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-021-02592-6","article-title":"Resistance to front-line malaria drugs confirmed in Africa","volume":"597","author":"Kozlov","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2024.107249_b0085","unstructured":"Medicine for Malaria Venture, (n.d.). https:\/\/www.mmv.org\/ (accessed March 27, 2023)."},{"key":"10.1016\/j.bioorg.2024.107249_b0090","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.3390\/molecules24224095","article-title":"The development of novel compounds against malaria: quinolines, triazolpyridines, pyrazolopyridines and pyrazolopyrimidines","volume":"24","author":"Pinheiro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107249_b0095","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/bi702218c","article-title":"Analysis of flavin oxidation and electron-transfer inhibition in plasmodium falciparum dihydroorotate dehydrogenase","volume":"47","author":"Malmquist","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2024.107249_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2022.107787","article-title":"Integrated structure-guided computational design of novel substituted quinolizin-4-ones as plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors","author":"Vyas","year":"2022","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/5539544","article-title":"Efforts made to eliminate drug-resistant malaria and its challenges","volume":"2021","author":"Amelo","year":"2021","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.bioorg.2024.107249_b0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/1062936X.2023.2247326","article-title":"3D-QSAR-based design, synthesis and biological evaluation of 2,4-disubstituted quinoline derivatives as antimalarial agents","volume":"34","author":"Vyas","year":"2023","journal-title":"SAR QSAR Environ. Res."},{"issue":"8","key":"10.1016\/j.bioorg.2024.107249_b0115","first-page":"25","article-title":"Structures of human dihydroorotate dehydrogenase in complex with antiproliferative agents","volume":"1993","author":"Liu","year":"2000","journal-title":"Struct. Lond. Engl."},{"key":"10.1016\/j.bioorg.2024.107249_b0120","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.4155\/fmc-2017-0250","article-title":"Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria","volume":"10","author":"Hoelz","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0125","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3390\/molecules23061254","article-title":"Synthesis, design, and structure-activity relationship of the pyrimidone derivatives as novel selective inhibitors of plasmodium falciparum dihydroorotate dehydrogenase","volume":"23","author":"Xu","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2024.107249_b0130","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/13543776.2023.2280596","article-title":"Recent advances on patents of plasmodium falciparum dihydroorotate dehydrogenase (pf DHODH) inhibitors as antimalarial agents","volume":"33","author":"Gehlot","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2024.107249_b0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10482-018-1168-8","article-title":"The pyrimidine biosynthetic pathway and its regulation in pseudomonas jessenii","volume":"112","author":"Murahari","year":"2019","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.bioorg.2024.107249_b0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/s41556-022-00965-1","article-title":"Vander heiden, nucleotide imbalance decouples cell growth from cell proliferation","volume":"24","author":"Diehl","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bioorg.2024.107249_b0145","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jmgm.2012.11.010","article-title":"In silico identification of novel inhibitors against plasmodium falciparum dihydroorate dehydrogenase","volume":"40","author":"Wadood","year":"2013","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bioorg.2024.107249_b0150","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bmcl.2009.11.079","article-title":"A study of the effects of substituents on the selectivity of the binding of N-arylaminomethylene malonate inhibitors to DHODH","volume":"20","author":"Cowen","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107249_b0155","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1039\/C6MD00024J","article-title":"Biological evaluation of quinoline derivatives as inhibitors of human dihydroorotate dehydrogenase","volume":"7","author":"Wang","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2024.107249_b0160","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1039\/C6MD00179C","article-title":"Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agents","volume":"7","author":"Song","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2024.107249_b0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","article-title":"Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery","volume":"4","author":"Luth","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107249_b0170","first-page":"226","article-title":"Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy, infect. disord. - drug","volume":"10","author":"Phillips","year":"2010","journal-title":"Targets"},{"key":"10.1016\/j.bioorg.2024.107249_b0175","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1073\/pnas.1101143108","article-title":"Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis","volume":"108","author":"Hoffmann","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2024.107249_b0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioorg.2024.107249_b0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.abb.2017.06.019","article-title":"The dihydroorotate dehydrogenases: past and present","volume":"632","author":"Reis","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2024.107249_b0190","doi-asserted-by":"crossref","DOI":"10.4155\/fmc-2023-0113","article-title":"Medicinal chemistry approaches for the discovery of plasmodium falciparum dihydroorotate dehydrogenase inhibitors as antimalarial agents","author":"Vyas","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0195","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acsmedchemlett.7b00030","article-title":"Discovery of antimalarial Azetidine-2-carbonitriles that inhibit P. falciparum dihydroorotate dehydrogenase","volume":"8","author":"Maetani","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107249_b0200","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1021\/acs.jafc.1c01173","article-title":"Phytocompounds targeting metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways, and therapeutic relevance","volume":"69","author":"Khan","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111681","article-title":"Dihydroorotate dehydrogenase inhibitors in anti-infective drug research","volume":"183","author":"Boschi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biocel.2018.10.007","article-title":"Enzymes of pyrimidine salvage pathways in intraerythrocytic plasmodium falciparum","volume":"105","author":"Naguib","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bioorg.2024.107249_b0215","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/1062936X.2016.1189959","article-title":"Identification of novel pf DHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity","volume":"27","author":"Vyas","year":"2016","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.bioorg.2024.107249_b0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1107\/S0907444905042642","article-title":"Structure of plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor","volume":"62","author":"Hurt","year":"2006","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bioorg.2024.107249_b0225","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.1021\/bi8003318","article-title":"The structures of human dihydroorotate dehydrogenase with and without inhibitor reveal conformational flexibility in the inhibitor and substrate binding sites","volume":"47","author":"Walse","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2024.107249_b0230","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-3024.1986.tb00867.x","article-title":"Multiple cross-reactivities amongst antigens of plasmodium falciparum impair the development of protective immunity against malaria","volume":"8","author":"Anders","year":"1986","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.bioorg.2024.107249_b0235","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0092-8674(03)01023-7","article-title":"Plasmodium biology","volume":"115","author":"Aravind","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.bioorg.2024.107249_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114737","article-title":"Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold","volume":"243","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0245","doi-asserted-by":"crossref","first-page":"26999","DOI":"10.1074\/jbc.M109.028589","article-title":"Structural plasticity of malaria dihydroorotate dehydrogenase allows selective binding of diverse chemical scaffolds","volume":"284","author":"Deng","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0250","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1021\/jm200592f","article-title":"Structure-guided Lead optimization of triazolopyrimidine-ring substituents identifies potent plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential","volume":"54","author":"Coteron","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0255","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/jm500481t","article-title":"Fluorine modulates species selectivity in the triazolopyrimidine class of plasmodium falciparum dihydroorotate dehydrogenase inhibitors","volume":"57","author":"Deng","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0260","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1021\/acs.jmedchem.6b00275","article-title":"Tetrahydro-2-naphthyl and 2-indanyl triazolopyrimidines targeting plasmodium falciparum dihydroorotate dehydrogenase display potent and selective antimalarial activity","volume":"59","author":"Kokkonda","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0265","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acsinfecdis.6b00144","article-title":"A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria","volume":"2","author":"Phillips","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2024.107249_b0270","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1021\/acsomega.8b01573","article-title":"Isoxazolopyrimidine-based inhibitors of plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity","volume":"3","author":"Kokkonda","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2024.107249_b0275","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1021\/acs.jmedchem.0c00311","article-title":"Lead optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series for the treatment of malaria","volume":"63","author":"Kokkonda","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0280","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1021\/acs.jmedchem.1c00173","article-title":"Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series","volume":"64","author":"Palmer","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0285","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/jm8001026","article-title":"Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite plasmodium falciparum","volume":"51","author":"Phillips","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0290","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/jm801343r","article-title":"Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice","volume":"52","author":"Gujjar","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0295","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1021\/jm200265b","article-title":"Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice","volume":"54","author":"Gujjar","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0300","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1021\/jm300157n","article-title":"Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases","volume":"55","author":"Bedingfield","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0305","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1021\/jm300351w","article-title":"Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against plasmodium falciparum dihydroorotate dehydrogenase","volume":"55","author":"Marwaha","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0310","doi-asserted-by":"crossref","unstructured":"S. Bhagat, A. Gahlawat, P.V. Bharatam, Structure-Based Drug Design of PfDHODH Inhibitors as Antimalarial Agents, in: C.G. Mohan (Ed.), Struct. Bioinforma. Appl. Preclin. Drug Discov. Process, Springer International Publishing, Cham, 2019: pp. 177\u2013220. https:\/\/doi.org\/10.1007\/978-3-030-05282-9_6.","DOI":"10.1007\/978-3-030-05282-9_6"},{"key":"10.1016\/j.bioorg.2024.107249_b0315","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.bmc.2005.01.017","article-title":"Synthesis of brequinar analogue inhibitors of malaria parasite dihydroorotate dehydrogenase","volume":"13","author":"Boa","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0320","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/jm060687j","article-title":"Design and synthesis of potent inhibitors of the malaria parasite dihydroorotate dehydrogenase","volume":"50","author":"Heikkil\u00e4","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0325","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1021\/jm800963t","article-title":"Structure-based design, synthesis, and characterization of inhibitors of human and plasmodium falciparum dihydroorotate dehydrogenases","volume":"52","author":"Davies","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0330","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1039\/c1md00118c","article-title":"N-substituted salicylamides as selective malaria parasite dihydroorotate dehydrogenase inhibitors","volume":"2","author":"Fritzson","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.bioorg.2024.107249_b0335","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00044-010-9323-4","article-title":"Molecular modeling studies, synthesis and biological evaluation of derivatives of N-phenylbenzamide as plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors","volume":"20","author":"Desai","year":"2011","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2024.107249_b0340","doi-asserted-by":"crossref","first-page":"7911","DOI":"10.1021\/jm400938g","article-title":"Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives","volume":"56","author":"Xu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0345","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1021\/jm501127s","article-title":"Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase","volume":"58","author":"Zhu","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0350","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejmech.2016.09.073","article-title":"Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-plasmodium falciparum, antimalarial, and pf-dihydroorotate dehydrogenase inhibitors","volume":"126","author":"Azeredo","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0355","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1016\/j.bmcl.2017.06.052","article-title":"Interconvertible geometric isomers of plasmodium falciparum dihydroorotate dehydrogenase inhibitors exhibit multiple binding modes","volume":"27","author":"McConkey","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107249_b0360","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1021\/ml200143c","article-title":"Optimization of potent inhibitors of P. falciparum dihydroorotate dehydrogenase for the treatment of malaria","volume":"2","author":"Skerlj","year":"2011","journal-title":"ACS Med Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107249_b0365","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.044","article-title":"Hydroxyazole scaffold-based plasmodium falciparum dihydroorotate dehydrogenase inhibitors: synthesis, biological evaluation and X-ray structural studies","volume":"163","author":"Pippione","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0370","doi-asserted-by":"crossref","first-page":"21847","DOI":"10.1074\/jbc.M501100200","article-title":"High-throughput screening for potent and selective inhibitors of plasmodium falciparum dihydroorotate dehydrogenase","volume":"280","author":"Baldwin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0375","doi-asserted-by":"crossref","first-page":"7425","DOI":"10.1021\/jm300351w","article-title":"Bioisosteric transformations and permutations in the triazolopyrimidine scaffold to identify the minimum pharmacophore required for inhibitory activity against plasmodium falciparum dihydroorotate dehydrogenase","volume":"55","author":"Marwaha","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112941","article-title":"Comparative study between the anti-P. falciparum activity of triazolopyrimidine, pyrazolopyrimidine and quinoline derivatives and the identification of new PfDHODH inhibitors","volume":"209","author":"Silveira","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107249_b0385","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:51:00Z","timestamp":1758617460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":77,"alternative-id":["S0045206824001548"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107249","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review of synthetic strategies and SAR studies for the discovery of PfDHODH inhibitors as antimalarial agents. Part 1: triazolopyrimidine, isoxazolopyrimidine and pyrrole-based (DSM) compounds","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107249"}}